Literature DB >> 27810424

Prediction of severe retinopathy of prematurity using the screening algorithm WINROP in preterm infants.

Nurullah Koçak1, Leyla Niyaz2, Nursen Ariturk2.   

Abstract

PURPOSE: To assess the sensitivity and specificity of weight gain, insulin-like growth factor 1 (IGF-1), and neonatal retinopathy of prematurity (WINROP) algorithm to predict proliferative retinopathy of prematurity (ROP), in a Turkish population of preterm infants.
METHODS: The medical records of infants screened and monitored for ROP from 2007 to 2014 were analyzed retrospectively. Birth weights of infants born before 32 weeks' gestation were recorded on the WINROP online database system weekly until postmenstrual week 36. The sensitivity, specificity, and positive and negative predictive values of the WINROP algorithm were analyzed.
RESULTS: A total of 223 infants were included. WINROP yielded a low-risk result in 106 infants (48%) and a high-risk result (red alarm) in the remaining 117 infants (53%). The sensitivity of the WINROP online system was found to be 84.3% (27/32), whereas its specificity was found to be 52.8% (101/191). The time between the first alarm and treatment was 8.59 ± 3.92 (2-15) weeks. Using this algorithm, 106 infants would not have needed eye examinations, possibly resulting in a 40% decrease in the total number of examinations.
CONCLUSIONS: The WINROP online system is a valuable and easy-to-use monitoring system that could decrease the number of infant ROP examinations. Copyright Â
© 2016 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27810424     DOI: 10.1016/j.jaapos.2016.08.008

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  8 in total

1.  Prediction of severe retinopathy of prematurity using the weight gain, insulin-like growth factor 1, and neonatal retinopathy of prematurity algorithm in a Japanese population of preterm infants.

Authors:  Kaori Ueda; Akiko Miki; Shunichiro Nakai; Suiho Yanagisawa; Koji Nomura; Makoto Nakamura
Journal:  Jpn J Ophthalmol       Date:  2020-01-03       Impact factor: 2.447

2.  Use of an online screening algorithm - Weight, Insulin-derived growth factor 1, Neonatal Retinopathy of Prematurity (WINROP) for predicting retinopathy of prematurity in Indian preterm babies.

Authors:  Smith Snehal Sute; Suksham Jain; Deepak Chawla; Subina Narang
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

3.  WINROP algorithm for prediction of sight threatening retinopathy of prematurity: Initial experience in Indian preterm infants.

Authors:  Gaurav Sanghi; Anil Narang; Sunny Narula; Mangat R Dogra
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

4.  Efficacy of WINROP as a Screening Tool for Retinopathy of Prematurity in the East Coast of Malaysia.

Authors:  Zi Di Lim; Kok Tian Oo; Evelyn Li Min Tai; Ismail Shatriah
Journal:  Clin Ophthalmol       Date:  2020-04-24

5.  The Use of Postnatal Weight Gain Algorithms to Predict Severe or Type 1 Retinopathy of Prematurity: A Systematic Review and Meta-analysis.

Authors:  Sam Athikarisamy; Saumil Desai; Sanjay Patole; Shripada Rao; Karen Simmer; Geoffrey C Lam
Journal:  JAMA Netw Open       Date:  2021-11-01

6.  Validation of the DIGIROP-birth model in a Chinese cohort.

Authors:  Sizhe Chen; Rong Wu; He Chen; Wenbei Ma; Shaolin Du; Chao Li; Xiaohe Lu; Songfu Feng
Journal:  BMC Ophthalmol       Date:  2021-05-27       Impact factor: 2.209

7.  Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Saudi cohort of preterm infants.

Authors:  Lina H Raffa; Sara K Alessa; Aliaa S Alamri; Rawan H Malaikah
Journal:  Saudi Med J       Date:  2020-06       Impact factor: 1.484

8.  Comment on: Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Saudi cohort of preterm infants.

Authors:  Sarar Mohamed
Journal:  Saudi Med J       Date:  2020-08       Impact factor: 1.484

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.